Labcorp Q2 revenue slightly beats estimates, lifts 2026 outlook

Labcorp Holdings

30/07/2026 12:01

Overview
U.S. laboratory services provider's Q2 revenue up 5.8%, slightly beating analyst expectations
Adjusted EPS for Q2 rose 14.9% to $4.99
Company raised 2026 revenue growth and adjusted EPS guidance, boosted share buyback by $1.0 bln

Outlook
Labcorp raises 2026 enterprise revenue growth guidance to 5.4%-6.3%
Company expects 2026 adjusted EPS between $18.10 and $18.55

Result Drivers
ORGANIC GROWTH AND OPERATING EFFICIENCIES - Co said increases in adjusted operating income and margin were due to organic growth and operating efficiencies
ONCOLOGY AND SPECIALTY TESTING - Co cited expansion in oncology offerings and high-growth specialty areas as drivers of business momentum
ACQUISITIONS AND NEW TEST LAUNCHES - Co said acquisitions and launches of new diagnostic tests, including nationwide rollout of ColoSense and new genetic health panels, contributed to growth

Company press release: ID:nPnb5RLPXa

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Slight Beat*
$3.73 bln
$3.71 bln (14 Analysts)
Q2 Adj EPS from Cont Ops
 
$4.99
 
Q2 EPS from Cont Ops
 
$3.64
 
*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 16 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for Labcorp Holdings Inc is $320.00, about 4.2% above its July 29 closing price of $307.15
The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 15 three months ago

Reuters Recommended Reads
July 28 - NeoGenomics Q2 revenue beats estimates, raises outlook
July 29 - GE Healthcare Q2 revenue rises 5.7% on Pharmaceutical Diagnostics unit strength
July 28 - IQVIA Q2 revenue beats estimates; outlook raised

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)